Follow-up imaging at 3, 6, 12 months and annually for small renal masses.
Monitor for complications and treatment success in all urological conditions with minimum six months follow-up.
Stone-free status assessed one month after ureteral stone treatment.
Risks
Consider risks of hospitalization, anesthesia, surgery, pain management, and potential mutilation.
Monitor for postoperative complications such as bleeding, infection, and thromboembolic events.
Account for the possibility of needing ancillary procedures if initial treatment fails.
Patient & Prescribing Data
758 patients treated for small renal masses, muscle-invasive bladder cancer, and upper ureteral stones at a tertiary center
Treatment modality selection was individualized; the Patient Burden Score provides a quantitative measure of treatment burden to complement success rates in decision-making.
Clinical Best Practices
Incorporate comprehensive burden assessment including expected, unexpected, and ancillary procedure burdens when counseling patients.
Use multidisciplinary input to assign weights reflecting patient treatment burden.
Apply the Patient Burden Score alongside clinical outcomes to guide personalized treatment choices.